Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Novavax Inc. (NVAX)

104.56   25.12 (31.62%) 07-07 16:00
Open: 104 Pre. Close: 79.44
High: 111.77 Low: 95.5
Volume: 26,286,069 Market Cap: 6,136M
Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company's lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate that in Phase III clinical trial to protect infants from RSV disease through maternal immunization; and NanoFlu, which is in Phase III clinical trial for treating seasonal influenza in older adults. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, and the immune systems attack against microorganisms, as well as to allow immunization with much lower doses of antigen.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 111.867 - 112.656 112.656 - 113.268
Low: 94.211 - 94.942 94.942 - 95.51
Close: 103.532 - 104.751 104.751 - 105.697

Technical analysis

as of: 2020-07-07 4:37:03 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 130.55     One year: 152.48
Support: Support1: 67.73    Support2: 40.50
Resistance: Resistance1: 111.77    Resistance2: 130.55
Pivot: 74.53
Moving Average: MA(5): 85.74     MA(20): 67.49
MA(100): 31.01     MA(250): 15.48
MACD: MACD(12,26): 12.19     Signal(9): 10.23
Stochastic oscillator: %K(14,3): 82.98     %D(3): 81.84
RSI: RSI(14): 80.38
52-week: High: 111.77  Low: 3.54  Change(%): 1938.2
Average Vol(K): 3-Month: 980635  10-Days: 997374

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NVAX has closed above the upper band by 7.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 188.1% wider than normal. The large width of the bands suggest high volatility as compared to NVAX's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Tue, 07 Jul 2020
Novavax Covid Vaccine Gets $1.6 Billion in U.S. Funding - Bloomberg

Tue, 07 Jul 2020
Shares Aiming Higher Pre-Bell: Novavax, Inc. (NASDAQ:NVAX) - Pineville

Tue, 07 Jul 2020
Novavax scores $1.6B contract for coronavirus vaccine, shifts flu strategy as capacity is ‘absorbed by Covid’ - Washington Business Journal

Mon, 06 Jul 2020
NVAX Stock Price: Novavax Inc.surging 34% after $1.6 billion COVID-19 vaccine candidate grant - FXStreet

Mon, 06 Jul 2020
Novavax, Inc. (NVAX) future in Healthcare Sector - The News Heater

Tue, 30 Jun 2020
Analysts Just Published A Bright New Outlook For Novavax, Inc.'s (NASDAQ:NVAX) - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 59
Shares Float (M) 54
% Held by Insiders 0.36
% Held by Institutions 13.89
Shares Short (K) 8,110
Shares Short P. Month (K) 7,360

Stock Financials

EPS -3.830
EPS Est This Year -0.620
EPS Est Next Year -0.550
Book Value (p.s.) -0.440
Profit Margin
Operating Margin -621.76
Return on Assets (ttm) -25.5
Return on Equity (ttm)
Qtrly Rev. Growth -15.2
Gross Profit (p.s.) -1.622
Sales Per Share 0.308
EBITDA (p.s.) -1.834
Qtrly Earnings Growth
Operating Cash Flow (M) -109
Levered Free Cash Flow (M) -63

Stock Valuations

PE Ratio -27.30
PEG Ratio
Price to Book value -237.64
Price to Sales 339.79
Price to Cash Flow -56.23

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.